Introduction
============

Heart Failure (HF) is the main cause of hospitalizations in the United States in patients older than 65 years old,^[@r1],[@r2]^ and is estimated to affect 26 million people worldwide.^[@r3]^ Its prevalence has been increasing fast due to aging of the population.^[@r1],[@r4]^ A higher life expectancy has been achieved with adherence to medical therapy, ventricular assist devices (VADs) and increase in the number of heart transplants.^[@r1]^

Paraiba is one of the nine states of the Northeast region of Brazil and had an estimated population in 2017 of 4,025,558 inhabitants, corresponding to the 13^th^ highest population among the 27 federative units of Brazil. The gross domestic product per capita of Paraiba was US\$3,594.94 in 2010, corresponding to fourth poorest state in the country, and the human development index in 2014 was 0.701, the 6^th^ lowest in the country.^[@r5],[@r6]^ Data regarding the epidemiology of HF in less developed countries are still limited and based mainly in cohorts of hospitalized patients or clinical trials.^[@r2]^ In Brazil, there is no data about the epidemiology of HF in Paraiba, and only a few reports on HF statistics in the Northeast region of Brazil.^[@r7],[@r8]^

A better understanding of the HF epidemiology in less developed areas of Brazil, as Paraiba, through a population-based study, could lead to a more effective and appropriate healthcare planning. The aim of this study was to describe and to perform a 10-year trend analysis of the HF morbidity and mortality in the state of Paraiba and in Brazil.

Methods
=======

Study model
-----------

This is a population-based time series analysis using the Hospital Information System (SIH/SUS), available at DATASUS (Department of Informatics of the Brazilian Unified Health System- SUS) database.^[@r6]^ DATASUS is responsible for the administration of health and financial information declared by all states and cities, and the federal district of Brazil. This database compiles information regarding health assistance, epidemiology, morbidity and demography.

Study population
----------------

The population of interest was composed by Brazilians older than 15 years that used any healthcare services under the primary diagnosis of HF, represented by the code I50 of the International Classification of Diseases 10^th^ Revision (ICD-10), between 2008 and 2017.

Variables
---------

Epidemiological data on HF were extracted, including absolute and relative mortality of the population, in-hospital mortality (absolute numbers), in-hospital mortality rate, number of hospital admissions and length of hospitalization. Variables were stratified by year, gender and age groups (15-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79 and ≥ 80 years). In-hospital data from the period of 2008 to 2017, and population data from 2008 to 2015 were available. The last population census conducted by the Brazilian Institute of Geography and Statistics (IBGE)^[@r5]^ in 2010 was also used.

Data analysis
-------------

Categorical variables were expressed as frequencies and continuous variables as mean ± standard deviation (SD).

In-hospital mortality rate from HF was obtained by dividing the number of all in-hospital HF deaths in Paraiba or Brazil by the number of hospitalizations for HF in the corresponding year. Population mortality rate from HF was calculated by dividing the number of all HF deaths in Paraiba or Brazil by the respective population in the corresponding year.

The Statistical Package for the Social Sciences (SPSS) version 21.0 (SPPS Inc., Chicago, USA) was used for the analysis. We used the Shapiro-Wilk's test to test the normality of data distribution for further analyses. The Pearson correlation was used to evaluate the correlation between numerical variables with normal distribution. The Chi-square test was performed using a contingency table and the linear-by-linear association test, also known as Mantel-Haenzsel test for trends, which is equivalent to the Cochran-Armitage test for trends available in other statistical packages.^[@r9]^ The level of significance was set at 5%.

Results
=======

Descriptive statistics of our variables are presented in [Table 1](#t1){ref-type="table"}.

###### 

Descriptive statistics of Heart Failure epidemiology in Paraiba, from 2008 to 2017

  Variables                                                                   Mean      Standard deviation   Shapiro-Wilk significance[\*](#TFN1){ref-type="table-fn"}
  --------------------------------------------------------------------------- --------- -------------------- -----------------------------------------------------------
  Deaths (population)^[†](#TFN2){ref-type="table-fn"}^                        739.88    32.92                0.385
  Women                                                                       387.88    24.07                0.916
  Men                                                                         349.63    17.71                0.099
  Deaths (in-hospital)                                                        474.50    95.52                0.324
  Women                                                                       238.80    46.15                0.763
  Men                                                                         234.70    52.04                0.161
  Population mortality rate (per 100,000) ^[†](#TFN2){ref-type="table-fn"}^   19.16     1.09                 0.775
  In-hospital mortality rate (per 100)                                        9.76      1.84                 0.659
  Number of admissions                                                        5117.20   1805.13              0.176
  Mean duration of hospitalization (days)                                     5.92      0.80                 0.121

In the Shapiro-Wilk test, the null hypothesis is that the population follows a normal distribution; if p \< 0.05, the data is not normally distributed;

Year interval: 2008-2015;

Source of data: SUS Information System (DATASUS) and Brazilian Institute of Geography and Statistics (2010).

Hospitalizations
----------------

The total number of HF admissions in Paraiba state between 2008 and 2017 was 51,172, representing the leading cause of hospitalizations due to cardiovascular diseases (29.4%), followed by other ischemic diseases of the heart (13%), stroke (11%), primary hypertension (10%) and acute myocardial infarction (5%). During the same period, HF was also the leading cardiovascular cause of hospitalization in Brazil, with 2,380,133 cases (21%). HF was responsible for 2.54% and 2.25% of all causes of hospitalization in Paraiba and in Brazil, respectively.

A downward trend in the absolute number of hospitalizations from HF in Paraiba and Brazil was observed between 2008 and 2017, corresponding to a decrease of 62% (R = -0.970; p = 0.004; [Table 2](#t2){ref-type="table"}; [Figure 1A](#f1){ref-type="fig"}) and 34% (R = -0.964; p = 0.004; [Table 3](#t3){ref-type="table"}; [Figure 1B](#f1){ref-type="fig"}), respectively. The frequency of males hospitalized for HF was 52% in Paraiba and 51% in Brazil.

###### 

Heart failure trends in Paraiba, from 2008 to 2017

  Variables                                 2008    2009    2010    2011    2012    2013    2014    2015    2016          2017          P values for trends[\*](#TFN3){ref-type="table-fn"}^[†](#TFN4){ref-type="table-fn"}^   Pearson (R)
  ----------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------------- ------------- -------------------------------------------------------------------------------------- -------------
  Number of deaths (population)             722     777     772     753     719     768     725     683     \-\-\-\-\--   \-\-\-\-\--   0.175                                                                                  -0.513
  Women                                     365     398     390     413     386     421     383     347     \-\-\-\-\--   \-\-\-\-\--   0.665                                                                                  -0.164
  Men                                       351     374     379     337     332     347     341     336     \-\-\-\-\--   \-\-\-\-\--   0.130                                                                                  -0.573
  Number of deaths (in-hospital)            472     588     581     561     551     462     461     374     378           317           0.013[\*](#TFN3){ref-type="table-fn"}                                                  -0.824
  Women                                     220     310     294     282     265     235     224     207     188           173           0.022[\*](#TFN3){ref-type="table-fn"}                                                  -0.762
  Men                                       252     278     287     279     286     227     237     167     190           144           0.012[\*](#TFN3){ref-type="table-fn"}                                                  -0.837
  Mortality rate (population)               19,25   20.53   20.21   19.55   18.51   19.62   18.38   17.19   \-\-\-\-\--   \-\-\-\-\--   0.047[\*](#TFN3){ref-type="table-fn"}                                                  -0.751
  Mortality rate (in-hospital)              6.60    8.50    7.90    8.50    10.10   9.8     11.20   12.00   12.10         10.90         0.006[\*](#TFN3){ref-type="table-fn"}                                                  0.917
  Women                                     6.35    9.32    8.52    9.02    10.08   10.39   11.49   13.56   12.69         11.93         0.006[\*](#TFN3){ref-type="table-fn"}                                                  0.908
  Men                                       6.76    7.67    7.36    8.15    10.20   9.12    11.02   10.61   11.59         9.40          0.013[\*](#TFN3){ref-type="table-fn"}                                                  0.828
  Number of admissions                      7143    6890    7331    6571    5450    4739    4102    3112    3115          2719          0.004[\*](#TFN3){ref-type="table-fn"}                                                  -0.970
  **Deaths per age range (population)**                                                                                                                                                                                         
  15-19 years                               2       2       3       2       1       0       1       1       \-\-\-\-\--   \-\-\-\-\--   0.067                                                                                  -0.693
  20-29 years                               3       8       8       5       5       6       2       6       \-\-\-\-\--   \-\-\-\-\--   0.588                                                                                  -0.205
  30-39 years                               8       16      9       13      9       10      10      8       \-\-\-\-\--   \-\-\-\-\--   0.389                                                                                  -0.326
  40-49 years                               21      22      29      23      25      23      24      13      \-\-\-\-\--   \-\-\-\-\--   0.292                                                                                  -0.399
  50-59 years                               47      42      53      33      45      48      46      36      \-\-\-\-\--   \-\-\-\-\--   0.479                                                                                  -0.267
  60-69 years                               84      88      92      75      92      101     82      93      \-\-\-\-\--   \-\-\-\-\--   0.457                                                                                  0.281
  70-79 years                               164     172     152     172     147     179     174     154     \-\-\-\-\--   \-\-\-\-\--   0.979                                                                                  -0.010
  Older than 80 years                       387     422     423     427     394     401     385     372     \-\-\-\-\--   \-\-\-\-\--   0.143                                                                                  -0.553
  **Deaths per age range (in-hospital)**                                                                                                                                                                                        
  15-19 years                               3       2       3       3       2       2       2       2       4             2             0.815                                                                                  -0.078
  20-29 years                               11      10      8       5       5       4       4       7       2             2             0.010[\*](#TFN3){ref-type="table-fn"}                                                  -0.859
  30-39 years                               17      19      16      11      16      12      7       8       6             8             0.008[\*](#TFN3){ref-type="table-fn"}                                                  -0.887
  40-49 years                               24      35      35      35      36      30      19      10      10            17            0.029[\*](#TFN3){ref-type="table-fn"}                                                  -0.727
  50-59 years                               55      53      53      55      63      47      46      24      38            35            0.025[\*](#TFN3){ref-type="table-fn"}                                                  -0.748
  60-69 years                               77      97      96      97      101     86      93      72      76            44            0.061                                                                                  -0.625
  70-79 years                               129     150     136     142     131     119     129     96      89            75            0.009[\*](#TFN3){ref-type="table-fn"}                                                  -0.865
  Older than 80 years                       149     213     227     211     194     157     156     153     148           129           0.052                                                                                  -0.649
  Mean duration of hospitalization (days)   5       5.2     5.3     5.5     5.6     5.6     6.1     6.5     7.2           7.2           0.004[\*](#TFN3){ref-type="table-fn"}                                                  0.953

p \< 0.05;

P value for trends according to the linear-by-linear association;

Source of data: SUS Information System (DATASUS) and Brazilian Institute of Geography and Statistics (count of 2010).

###### 

Heart failure trends in Brazil, from 2008 to 2017

  Variables                                 2008      2009      2010      2011      2012      2013      2014      2015      2016          2017          P values for trends[\*](#TFN5){ref-type="table-fn"}^[†](#TFN6){ref-type="table-fn"}^   Pearson (R)
  ----------------------------------------- --------- --------- --------- --------- --------- --------- --------- --------- ------------- ------------- -------------------------------------------------------------------------------------- -------------
  Number of deaths (population)             27,567    27,314    27,544    27,818    26,694    27,290    26,783    27,434    \-\-\-\-\--   \-\-\-\-\--   0.276                                                                                  -0.412
  Women                                     13,990    14,136    14,236    14,525    13,824    14,014    13,846    14,435    \-\-\-\-\--   \-\-\-\-\--   0.929                                                                                  0.034
  Men                                       13,428    13,047    13,159    13,130    12,756    13,166    12,825    12,900    \-\-\-\-\--   \-\-\-\-\--   0.069                                                                                  -0.689
  Number of deaths (in-hospital)            22,513    23,043    23,667    24,451    23,071    22,858    22,031    22,756    23,519        19,209        0.131                                                                                  -0.504
  Women                                     11,021    11,356    11,740    12,099    11,426    11,305    10,963    11,450    11,738        10,509        0.401                                                                                  -0.280
  Men                                       11,198    11,395    11,676    12,092    11,408    11,301    10,823    11,097    11,577        10,213        0.119                                                                                  -0.520
  Mortality rate (population)               14.54     14.26     14.44     14.46     13.76     13.57     13.21     13.42     \-\-\-\-\--   \-\-\-\-\--   0.017[\*](#TFN5){ref-type="table-fn"}                                                  -0.905
  Mortality rate (in-hospital)              8.3       8.5       8.9       9.4       9.5       9.7       9.8       10.5      11.0          10.8          0.003[\*](#TFN5){ref-type="table-fn"}                                                  0.981
  Women                                     8.5       8.7       9.2       9.6       9.8       10.0      10.2      11.0      11.5          11.2          0.003[\*](#TFN5){ref-type="table-fn"}                                                  0.980
  Men                                       8.2       8.4       8.7       9.2       9.3       9.4       9.6       10.1      10.6          10.4          0.003[\*](#TFN5){ref-type="table-fn"}                                                  0.985
  Number of admissions                      270,988   269,891   265,038   260,995   242,919   236,550   223,825   217,050   214,432       178,445       0.004[\*](#TFN5){ref-type="table-fn"}                                                  -0.964
  **Deaths per age range (population)**                                                                                                                                                                                                         
  15-19 years                               56        55        47        49        51        41        40        35        \-\-\-\-\--   \-\-\-\-\--   0.014[\*](#TFN5){ref-type="table-fn"}                                                  -0.926
  20-29 years                               206       204       180       176       165       174       159       145       \-\-\-\-\--   \-\-\-\-\--   0.012[\*](#TFN5){ref-type="table-fn"}                                                  -0.947
  30-39 years                               468       415       379       387       396       373       358       355       \-\-\-\-\--   \-\-\-\-\--   0.022[\*](#TFN5){ref-type="table-fn"}                                                  -0.863
  40-49 years                               1,039     1,002     1,034     957       913       920       836       815       \-\-\-\-\--   \-\-\-\-\--   0.011[\*](#TFN5){ref-type="table-fn"}                                                  -0.957
  50-59 years                               2,389     2,303     2,293     2,269     2,259     2,214     2,072     2,157     \-\-\-\-\--   \-\-\-\-\--   0.016[\*](#TFN5){ref-type="table-fn"}                                                  -0.910
  60-69 years                               4,296     4,249     4,196     4,268     4,057     4,230     4,123     4,255     \-\-\-\-\--   \-\-\-\-\--   0.328                                                                                  -0.370
  70-79 years                               7,178     7,027     7,062     7,013     6,727     6,969     6,707     6,845     \-\-\-\-\--   \-\-\-\-\--   0.037[\*](#TFN5){ref-type="table-fn"}                                                  -0.788
  Older than 80 years                       11,788    11,928    12,206    12,539    12,012    12,259    12,383    12,733    \-\-\-\-\--   \-\-\-\-\--   0.039[\*](#TFN5){ref-type="table-fn"}                                                  0.782
  **Deaths per age range (in-hospital)**                                                                                                                                                                                                        
  15-19 years                               87        97        75        73        61        65        59        61        61            38            0.007[\*](#TFN5){ref-type="table-fn"}                                                  -0.898
  20-29 years                               284       271       264       241       220       230       188       176       175           152           0.003[\*](#TFN5){ref-type="table-fn"}                                                  -0.984
  30-39 years                               597       529       503       501       475       451       445       437       434           369           0.008[\*](#TFN5){ref-type="table-fn"}                                                  -0.887
  40-49 years                               1,278     1,216     1,227     1,216     1,104     1,102     981       1,004     1,052         853           0.005[\*](#TFN5){ref-type="table-fn"}                                                  -0.931
  50-59 years                               2,687     2,722     2,736     2,793     2,700     2,620     2,372     2,498     2,569         2,149         0.019[\*](#TFN5){ref-type="table-fn"}                                                  -0.783
  60-69 years                               4,358     4,578     4,739     4,769     4,599     4,452     4,439     4,601     4,783         4,149         0.533                                                                                  -0.208
  70-79 years                               6,337     6,371     6,583     6,820     6,237     6,343     5,984     6,174     6,496         5,706         0.101                                                                                  -0.546
  Older than 80 years                       6,591     6,967     7,289     7,778     7,438     7,343     7,318     7,596     7,745         7,306         0.064                                                                                  0.617
  Mean duration of hospitalization (days)   6.5       6.4       6.5       6.6       6.7       6.9       7.1       7.3       7.4           7.3           0.004[\*](#TFN5){ref-type="table-fn"}                                                  0.960

p \< 0.05;

P value for trends according to the linear-by-linear association;

Source of data: SUS Information System (DATASUS) and Brazilian Institute of Geography and Statistics (count of 2010)

Figure 1Trends in absolute number of hospitalizations from heart failure from 2008 to 2017 in Paraiba (A) and regions of Brazil (B).

When stratified by age, individuals older than 60 years old corresponded to 71% and 73% of all the cases of HF admissions in Paraiba and Brazil, respectively, with the highest frequency in the age range from 70 to 79 years old.

Absolute mortality of population
--------------------------------

The absolute mortality from HF of the population showed a non-significant decline from 2008 to 2015 in Paraiba (R = -0.513; p = 0.175; [Table 2](#t2){ref-type="table"}) and Brazil (R = -0.412; p = 0.276; [Table 3](#t3){ref-type="table"}), with no difference by gender. Women represented 53% of deaths in Paraiba and 52% in Brazil. In Paraiba, the decrease in absolute deaths from HF in the population across all age categories was not statistically significant ([Table 2](#t2){ref-type="table"}).

Between 2008 and 2015, the highest proportion of deaths from HF occurred at the age group of ≥ 80 years old in both men and women in Paraiba (50% and 59%, respectively) and in Brazil (38% and 52%, respectively). The proportions of deaths from HF at the age ≥ 60 years old in Paraiba was 87% in men and 90% in women and, in Brazil, 83% in men and 89% in women.

Population mortality rate
-------------------------

The mean mortality rate from HF in the population was 19.2/100,000 (±1.09) in Paraiba and 14.0/100,000 (±0.53) in Brazil, with a significant decline of 10.7% (R = -0.751; p = 0.047; [Table 2](#t2){ref-type="table"}) in Paraiba and 7.7% (R = -0.905; p = 0.017; [Table 3](#t3){ref-type="table"}) in Brazil between 2008 and 2015, respectively ([Figure 2](#f2){ref-type="fig"}).

Figure 2Trends in population mortality rate (per 100,000 inhabitants) from heart failure in Paraiba (green) and Brazil (blue) from 2008 to 2015.

Absolute in-hospital mortality
------------------------------

The absolute in-hospital HF mortality, between 2008 and 2017, showed a significant decrease of 37.5% in Paraiba (R = -0.824; p = 0.013; [Table 2](#t2){ref-type="table"}; [Figure 3B](#f3){ref-type="fig"}) and a non-significant 14.6% decrease in Brazil (R = -0.504; p = 0.131; [Table 3](#t3){ref-type="table"}; [Figure 3B](#f3){ref-type="fig"}). In the stratified analysis, a significant decrease in the absolute in-hospital deaths from HF was observed for both men and women in Paraiba (R = -0.837; p = 0.012 and R = -0.762; p = 0.022; [Table 2](#t2){ref-type="table"}); this statistically significant trend by sex was not observed in Brazil ([Table 3](#t3){ref-type="table"}).

Figure 3(A) Trend of the in-hospital mortality rate from heart failure in Paraiba (green) and Brazil (blue) from 2008 to 2017; (B) trend of the in-hospital absolute mortality from heart failure in Paraiba (green) and Brazil (blue) from 2008 to 2017.

Individuals older than 80 years old presented the highest proportion of absolute in-hospital HF deaths in Paraiba and Brazil, from 2008 to 2017, (37% and 32%, respectively) ([Figure 4](#f4){ref-type="fig"}). In Paraiba, there was a statistically significant reduction in in-hospital deaths from HF for the age categories: 20-29 years (p = 0.010), 30-39 years (p = 0.008), 40-49 years (p = 0.029), 50-59 years (p = 0.025) and 70-79 years (p = 0.009) ([Table 2](#t2){ref-type="table"}).

Figure 4(A) Absolute in-hospital deaths from heart failure in Paraiba per age range, from 2008 to 2017. (B) Absolute in-hospital deaths from heart failure in Brazil per age range, from 2008 to 2017.

Further data on the absolute number of in-hospital deaths from HF per age range in Brazil are specified in [Table 3](#t3){ref-type="table"}.

In-hospital mortality rate
--------------------------

The in-hospital HF mortality rate increased significantly by 65.1% in Paraiba (R = 0.917; p = 0.006; [Table 2](#t2){ref-type="table"}), from 6.6% in 2008 to 10.9% in 2017, and by 30.1% in Brazil (R = 0.981; p = 0.003; [Table 3](#t3){ref-type="table"}), from 8.3% in 2008 to 10.8% in 2017 ([Figure 3A](#f3){ref-type="fig"}). The increase in in-hospital mortality rate from HF by gender was also significant for both men and women in Paraiba (R = 0.828; p = 0.013 and R = 0.908; p = 0.006, respectively; [Table 2](#t2){ref-type="table"}). This trend was also observed for both sex in Brazil, in a similar magnitude of effect (R = 0.985; R = 0.980; p = 0.003; [Table 3](#t3){ref-type="table"}).

The in-hospital HF mortality rate per age range was highest in individuals older than 80 years old, with a mean of 14.7% in Paraiba and 14.5% in Brazil ([Figure 5](#f5){ref-type="fig"}) from 2008 to 2017. In this age range, the in-hospital mortality rate from HF per gender in Paraiba was 12.4% in men and 15.2% in women, and in Brazil, 13.7% in men and 14.9% in women.

Figure 5(A) Trend of the in-hospital mortality rate from heart failure in Paraiba per year and age range, from 2008 to 2017. (B) Trend of the in-hospital mortality rate from heart failure in Brazil per year and age range, from 2008 to 2017.

Length of hospital stay
-----------------------

The average length of hospital stay for HF was 5.9 days (±0.8) in Paraiba and 6.9 days (±0.4) in Brazil, with a significant increase of 44% (R = 0.953; p = 0.004; [Table 2](#t2){ref-type="table"}) and 12.3% (R = 0.960; p = 0.004; [Table 3](#t3){ref-type="table"}), respectively, between 2008 and 2017 ([Figure 6](#f6){ref-type="fig"}). In [Table 4](#t4){ref-type="table"}, we present the duration of hospital stay per year, and the associated cost, both in Paraiba and Brazil.

Figure 6Trends in the mean length of stay (days) from heart failure hospitalizations in Paraiba (green) and Brazil (blue) from 2008 to 2017

###### 

Total cost of HF hospitalizations (US\$) and duration of HF admission (days) in Paraiba and Brazil, from 2008 to 2017

          PARAÍBA         BRAZIL                                   
  ------- --------------- ----------------------- ---------------- -----------------------
  2008    1,762,825.91    5                       77,940,473.93    6.5
  2009    2,286,531.90    5.2                     89,837,575.25    6.4
  2010    2,541,429.71    5.3                     92,835,802.31    6.5
  2011    2,378,139.40    5.5                     93,939,042.90    6.6
  2012    1,939,284.53    5.6                     91,509,632.22    6.7
  2013    1,694,005.09    5.6                     93,561,446.18    6.9
  2014    1,578,506.24    6.1                     96,199,113.56    7.1
  2015    1,233,302.85    6.5                     99,069,494.68    7.3
  2016    1,249,580.27    7.2                     102,181,019.88   7.4
  2017    1,103,600.05    7.2                     85,390,241.41    7.3
  Total   17,767,205.95   5.9 ± 0.8 (mean ± SD)   922,463,842.32   6.9 ± 0.4 (mean ± SD)

SD: standard deviation;

Source of data: SUS Information System (DATASUS) and Brazilian Institute of Geography and Statistics (count of 2010)

Discussion
==========

To our knowledge, this is the first study to describe the trends of HF epidemiology in a less developed region of Brazil. Information regarding the incidence, prevalence, morbidity and mortality of HF in Latin America and the Caribbean (LAC) are heterogeneous and scarce. Most of the data come from South America (92%), with 86% of the studies conducted in Brazil and Argentina.^[@r10]^ In Brazil, most of the published data come from developed areas, the Southeast and South regions.

HF was the leading cause of hospitalizations among cardiovascular diseases in Paraiba and Brazil, and corresponded to 2.54% and 2.25% of all admissions, respectively. Similarly, in the U.S., HF was the cause of more than 1 million admissions per year from 2001 to 2009,^[@r11]^ and represented 1-2% of all hospitalizations.^[@r3]^

Fang et al.^[@r12]^ performed a study to determine the trends in HF in the U.S. using the National Hospital Discharge Survey data from 1979 to 2004, and observed an increase of 185% in the absolute number of HF admissions (from 409,000 to 1,166,000) and the HF hospitalization rates (per 100,000) increased from 219 to 390 during the same period. Other authors, however, have reported that the number of primary hospitalizations for HF have been decreasing in the U.S. between 1.0% to 4.3% per year since 2001.^[@r11],[@r13]^ In the LAC, Godoy et al.^[@r14]^ showed a 32% decrease in HF admissions, between 1992-1993 and 2008-2009, which is consistent with our findings of a 34% decrease in the absolute number of hospitalizations for HF in Brazil, and 62% in Paraiba. This observed reduction can be a sign of improvement in the overall management of the risk factors for HF,^[@r4]^ a decrease in the incidence of ischemic heart disease,^[@r15]^ and an improvement in HF management.^[@r16]^

Hospitalizations for HF in Paraiba and Brazil were more common for individuals between the ages of 70 to 79 years old. Individuals older than 60 years old represented 71% and 73% of admissions for HF in Paraiba and Brazil, respectively; this is similar to the frequency (70%) reported in previous studies in LAC and U.S..^[@r2],[@r4]^ In Paraiba and in Brazil, the proportion of women hospitalized for HF was 48% vs 49%, similar to studies in the U.S., with 40% to 50% of women.^[@r3],[@r17]^ A small study performed in a community in Brazil reported that 58% of hospitalized patients with HF were women.^[@r18]^ Also, the I Brazilian Registry of Heart Failure (BREATHE registry)^[@r8]^ describes that 60% of 1,263 admissions for HF in 51 centers of Brazil were women.

In our study, mean mortality rate for HF in the population between 2008 to 2015 was 19.2/100,000 (±1.09) cases in Paraiba and 14.0/100,000 (±0.53) cases in Brazil, with a decline of 10.7% and 7.7%, respectively. A decrease in the mortality rate for HF was also reported in Brazil and Argentina: in Sao Paulo, Brazil's largest city, there was a 29% decrease, from 19.1/100,000 (1992-1993) to 13.6/100,000 (2008-2009);^[@r14]^ in Argentina, a nationwide study showed a reduction of 23% in the population HF mortality rate from 1995 to 2005.^[@r10],[@r19]^ In the U.S., Go et al.^[@r20]^ compared the absolute number of HF deaths from 1995 to 2010, and found a decrease of 2.8% (287,000 vs 279,000), which potentially represents a significant decrease in the mortality rate, given the increase in the US population over 15 years.

Our study reports a mean in-hospital mortality rate for HF in Paraiba of 9.2% between 2008 and 2017. A prospective study performed in 51 centers from all the Brazilian regions, only with patients hospitalized due to acute HF, reported a total of 12.6% deaths in 1,263 hospitalized patients.^[@r8]^ In the LAC, a meta-analysis of 37 studies revealed a similar in-hospital mortality of 11.7%.^[@r10]^

Our study demonstrated an increase in the in-hospital mortality rate for HF, both in Paraiba and in Brazil (65% and 30%, respectively), between 2008 and 2017. Godoy et al.,^[@r14]^ between 1992-1993 and 2008-2009, also reported a 15% increase in the previous 15% in-hospital mortality rate in Brazil. In the U.S., however, the in-hospital mortality rate decreased from 4.5% in 2001 to 2.9% in 2014 according to a study that included patients with a primary diagnosis of HF.^[@r13]^ The decrease in the number of hospitalizations for HF during the study period, both in Paraiba and Brazil, is the most likely reason for the increased in-hospital mortality rate. Another plausible explanation could be the increased survival of HF patients, leading to a higher number of elderly patients, with more advanced HF and multiple comorbidities, and increased risk of death during hospitalization. Lastly, it is important to consider the lack of advanced therapies in less developed areas, as mechanical devices and heart transplantation, contributing to this trend of increased HF mortality rate in Paraiba, Brazil and LAC.

Although there was an increase in the in-hospital mortality rate, absolute in-hospital mortality showed a significant decrease of 37.5% in Paraiba and 14.6% in Brazil for the same period. In the U.S., Bueno et al.^[@r21]^ also observed a 50% decrease in the in-hospital mortality for HF in a population of elderly Medicare patients, from 1993 to 2008, and Ni and Xu,^[@r22]^ a 30% decrease.

Women represented 53% and 52% of the absolute mortality for HF in Paraiba and Brazil, respectively. The in-hospital mortality for HF in Paraiba had a similar proportion of women (50.5%). In the U.S., in 2010, 54.6% of all HF deaths happened in women.^[@r20]^ Hsich et al.^[@r23]^ observed no difference in the in-hospital mortality between women and men considering both the reduced and preserved ejection fraction groups.

Between 2008 and 2017, the mean duration of hospitalization for HF was 5.9 (±0.8) days in Paraiba and 6.8 (±0.4) days in Brazil, with an increase of 44% and 12.3%, respectively. In the LAC, Bocchi et al.^(2,\ 24)^ found a mean hospital stay of 5.8 days between 1998 and 2012. Ciapponi et al.^[@r10]^ reported an average of 7 days in 18 studies, and Godoy et al.^[@r14]^ found an increase of 25% in the length of stay, from 8.8 (1992-1993) to 11.3 days (2008-2009) in Brazil. In the U.S., two authors reported a decrease in the length of stay due to HF, from 8.8 to 6.3 days (1993-2008)^[@r21]^ and from 6.8 days (1999-2000) to 6.4 days (2007-2008).^[@r4]^

In the U.S., the per capita cost with healthcare was greater than the per capita gross domestic product of Paraiba (US\$8,364.00 and US\$3,594.94, respectively).^[@r24]^ The lower socioeconomic status in Paraiba may represent a risk factor for the high morbidity and mortality observed in our study, because the population has limited access to effective HF treatment.^[@r24]^ In the U.S., 52.5% of people with a household income less than US\$10,000 suffer from a cardiovascular disease^[@r20],[@r25]^ and Eapen et al.^[@r26]^ found that a higher income was associated with lower odds of 30-day mortality after a HF admission.

Limitations
-----------

This is a retrospective and observational study, and the lack of patient-level data limited our ability to establish relationship between variables. Since our data was derived from a national database, it is likely that underreporting and misreporting of data have occurred. Also, since readmissions are not considered in the total number of HF hospitalizations, in-hospital mortality rate may have been underestimated.

Conclusions
===========

This is the first study to analyze the epidemiology of HF in Paraiba, a less developed state of Brazil, and to compare the results with national and international data. Over the last 10 years, the increase of the in-hospital mortality rate for HF in Paraiba and in Brazil followed the LAC trend, whereas the increase in the duration of hospitalization for HF is opposite to the decrease seen in the U.S.. In Paraiba and Brazil, we observed a decrease in admission for HF as primary diagnosis as well as in the absolute in-hospital deaths for HF, agreeing with the LAC and U.S.. More than 87% of the HF deaths in Paraiba and Brazil involved patients older than 60 years old. There was a higher frequency of woman admitted for HF, both in Paraiba and Brazil, with similar mortality rates when compared to men. Since women are generally underrepresented in clinical trials, there is a need for more studies focusing on that population. Hospital-based clinical studies should be performed to identify the causes for the trend of increase in in-hospital mortality rate for HF.
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